FactsheetofHealthStatistics 2018

Relaterede dokumenter
FactsheetofHealthStatistics 2018

FactsheetofHealthStatistics 2018

FactsheetofHealthStatistics 2018

FactsheetofHealthStatistics 2018

FactsheetofHealthStatistics 2018

FactsheetofHealthStatistics 2018

FactsheetofHealthStatistics 2018

FactsheetofHealthStatistics 2018

FactsheetofHealthStatistics 2018

FactsheetofHealthStatistics 2018

FactsheetofHealthStatistics 2018

FactsheetofHealthStatistics 2018

FactsheetofHealthStatistics 2018

FactsheetofHealthStatistics 2018

FactsheetofHealthStatistics 2018

FactsheetsofHealthStatistics 2016

SUNDHED OG VAND; FØR, NU OG FREMOVER. ATV Jord og Grundvand 06/03/2019

Cohort of HBV and HCV Patients

Sport for the elderly

Measuring Evolution of Populations

Henrik Thiesen / SundhedsTeam & RED LIV / Center for Udsatte Voksne og Familier

Hvordan får vi bugt med det fedmefremmende samfund?

HIV and Drug Prevention in Estonian Prisons

Vælg layout/design Nyt dias Fremhæv et eller flere ord i overskriften Bold Vis hjælpelinjer som hjælp ved placering af objekter

OBSERVERENDE UNDERSØGELSER. Kim Overvad Institut for Epidemiologi og Socialmedicin Aarhus Universitet Forår 2002

Samlet oversigt. General survey

Husstande og familier

Husstande og familier. Households and families

Eksempler på anvendelse af registre og surveys til forskning om social ulighed i middellevetid og forventet levetid med godt helbred

Trening/kamptider kunstgress 2014

Hvad belaster og hvad beskytter soldater med selvmordstanker og selvmordsforsøg?

Antal døde Fordeling af gnsntl gnsntl gnsntl gnsntl under 1 år

Medicinske komplikationer efter hofte- og knæalloplastik (THA and KA) med fokus på trombosekomplikationer. Alma B. Pedersen

Hovedtraumer.

Kapitel 3. FØDSELSSTATISTIK

Kapitel 3. FØDSELSSTATISTIK

Kapitel 3. FØDSELSSTATISTIK

Lovkrav vs. udvikling af sundhedsapps

Velkommen til Lægedage

System Management Principles Statement

Udledninger fra brændeovne og effekten på sundhed

DANSKE MÆNDS SÆDKVALITET - EN OPDATERING

Hvordan går det danske patienter med testis cancer?

Susan E. Moore, Director Chris Harper, Work First Program Manager

Kapitel 9. DØDSÅRSAGER

System Management Principles Statement

78 - Dødsfald. Tabel 24. Dødeligheden Mortality Døde fordelt efter dødsmåned Deaths by month of death. Døde pr. 1.

Røntgenundersøgelser af columna lumbalis indblændning ved analog vs. digital teknik

Epidemiology of Headache

Population Assessment. Heather Curtis NURS 7356 July 17, 2014

Prioritering eller ej? Hvad er Konsekvensen? Jens Winther Jensen. Lægeforeningen

Søvnapnø, type II diabetes og tabt arbejdsmarkedsfortjeneste - et sundhedsøkonomisk perspektiv

Social ulighed i Sundhed: Empiri og årsager

Strandskade Haematopus ostralegus Tjaldur Oystercatcher

UNISONIC TECHNOLOGIES CO.,

Infertilitet sygdomme der ikke forebygges. Søren Ziebe Klinikchef Fertilitetsklinikken Rigshospitalet

Statistik ved Bachelor-uddannelsen i folkesundhedsvidenskab. Mål for sammenhæng mellem to variable

Figur trafik 1. Antal tilskadekomne behandlet på skadestuen, Figur trafik 2.

Statistikøvelse Kandidatstudiet i Folkesundhedsvidenskab 28. September 2004

Supermarkeder og Smart Grid muligheder for fleksibelt elforbrug

Statistik ved Bachelor-uddannelsen i folkesundhedsvidenskab. Estimation

Kommentarer til det dansk/svenske registerstudie:

Impala Platinum 10 Shaft Decline Analyst Visit - 25 October 2002

Global sundhed. Er lægevidenskaben død eller har den bare åndenød? Morten Sodemann, Global Sundhed, SDU-Sundhedsvidenskab

Tidlig palliativ indsats - overvejelser ift. klinik og forskning

Viden i sundhedsregistrene til rådighed for virksomhederne? - Et par eksempler fra vellykket offentlig-privat samarbejde

Kommentarer til spørgsmålene til artikel 1: Ethnic differences in mortality from sudden death syndrome in New Zealand, Mitchell et al., BMJ 1993.

Drømmer du om en karriere i USA?

Databaserne, indikatorer og forskning

Task Force on European Standard Population. Eurostat, Unit F5 Monica Pace

Barnets navn: Børnehave: Kommune: Barnets modersmål (kan være mere end et)

Morbidity and Mortality

Danish Language Course for International University Students Copenhagen, 12 July 1 August Application form

Family Group Record for Jens Nielsen Page 1 (1 of 4) Husband Jens Nielsen Born. Maren Pedersen

Anvendelse af Sygesikringsregisteret:

Morten Rasmusen Overlæge Ph.-D Abdominalcenter K Bispebjerg Hospital Chef for tarmkræftscreening i Region Hovedstaden

Hvordan går det børn med ASF senere i livet? Hvordan måler man outcome? - Outcome -undersøgelser. 1. Normativ vurdering:

Undervisningsbeskrivelse

Indeklima i danske skoler og kontorer. Jørn Toftum

Definisjoner og dilemmaer

Children s velomobility how cycling children are made and sustained

Danish Language Course for Foreign University Students Copenhagen, 13 July 2 August 2016 Advanced, medium and beginner s level.

Fertilitetsrådgivning koncept og resultater efter de første 5 år

Evidensprofiler - NKR om hysterektomi (fjernelse af livmoderen) ved godartet sygdom

Screened electronic cable LiYCY

PEMS RDE Workshop. AVL M.O.V.E Integrative Mobile Vehicle Evaluation

Morten Frydenberg 25. april 2006

Hvad er kilderne til forurening i vores boliger?

Small Autonomous Devices in civil Engineering. Uses and requirements. By Peter H. Møller Rambøll

AitkinCounty PerformanceReport

Kapitel 9. TOQUNERMUT PISSUTAASARTUT

25. april Probability of Developing Coronary Heart Disease in 6 years. Women (Aged 35-70) 160 No Yes

9. Chi-i-anden test, case-control data, logistisk regression.

Hvor mange har egentlig kræft?

Hastegradsvurdering i Danmark Dansk Indeks for Akuthjælp, anvendelse og forskning

August2017. ReportingPeriods ChildSafetyandPermanency:Jan.1,2016 Dec.31,2016 MFIP/DWPSelf-SupportIndex:April2016 March2017

Nordisk skattevidenskabelig forskningsråds seminar om pensionsbeskatning København, den 26. og 27. oktober 2006

Samfundsudvikling og valg af metoder: Didaktiske udfordringer

Association between occupational exposures and gestational hypertension, preeclampsia, and gestational diabetes in Sweden,

Karyn Heavner, Carl V. Phillips, Patrik Hildingsson, Lisa Cockburn

Transkript:

NAMIBIA FactsheetofHealthStatistics 218

Demographicandsocioeconomicstatistics Population(Datasource:WHO andworldbank218) Population(in thousands)total Populationproportion under15(%) Populationlivingon Populationproportion Populationmedianage Ruralpopulation(% of <$1(PPPint.$)aday over6(%) (years) totalpopulation) (%) 27-213 24 21 211 212 213 214 215 21 21 58 57 56 55 54 53 216 2,48 37 217 51 21 211 212 213 214 215 Lifeexpectancyatbirth(years) Bothsexes 61 61.8 62.7 63.3 63.6 63.4 63.2 64.3 65.4 65.9 66.1 65.7 58.7 59.2 59.8 6.4 6.8 6.9 216 63.7 66.1 61.1 Lifeexpectancy(Datasource:WHO 218) Lifeexpectancyatage6(years) Both sexes 16.4 16.4 16.5 16.6 16.7 16.7 16.7 Healthylifeexpectancy(HALE)at birth(years) Bothsexes 17.4 17.5 17.6 17.6 17.7 17.7 17.8 15.1 15.1 15.2 15.3 15.3 15.3 15.3 53.4 55.6 55.9 55.1 57.6 57.9 51.5 DRAFT 53.6 53.8 52 Healthylifeexpectancy(HALE)at age6(years) Both sexes 12.4 12.7 12.8 13.2 13.6 13.7 11.3 11.6 11.6 5 Crudebirthanddeathrates(per1,people)(Datasource:WHO 218) Numberper1,people 4 3 2 1 3. 9.9 Birth 3.2 3.1 3.1 9.3 8.7 8.2 Death 29.9 7.8 29.6 7.5 29.2 7.2 21 211 212 213 214 215 216

Mortalityandmorbidity 5 Adultmortalityrate(Datasource:WHO 218) Probabilityofdyingbetween15and6yearsper1 population 4 3 2 372 289 264 362 351 242 343 339 235 239 341 344 255 253 1 21 211 212 213 214 215 216 Age-standardizeddeathrateper1populationbybroader causes (Datasource:WHO 218) Noncommunicablediseases 71 Age-standardizeddeathrateper1populationbycommunicable diseasesgroups (Datasource:WHO 218) Infectiousandparasiticdiseases 21 216 394 334 671 RespiratoryInfectious 111 96 Communicable,maternal, perinatalandnutritional conditions 563 Neonatalconditions 34 3 478 Maternalconditions 13 9 Injuries 91 88 Year 21 216 Nutritionaldeficiencies 11 9 Age-standardizeddeathrateper1populationby noncommunicablediseasesgroups(datasource:who 218) Cardiovasculardiseases Malignantneoplasms Diabetesmelitus Respiratorydiseases Neurologicalconditions Digestivediseases Genitourinarydiseases Congenitalanomalies Endocrine,blood,immunedisorders Skindiseases Mentalandsubstanceusedisorders Otherneoplasms Musculoskeletaldiseases Oralconditions Senseorgandiseases 21 216 34 78 75 74 45 4 25 8 9 5 5 3 2 316 75 74 67 47 37 24 8 8 5 5 3 2 Age-standardizeddeathrateper1populationbyinjuriesin216 (Datasource:WHO 218) Roadinjury 3 Interpersonalviolence 19 Self-harm 12 Fire,heatandhot substances 5 Drowning 4 Other unintentional injuries 9 Fals 4 Poisonings

Childhealthandnutrition Immunization(Datasource:WHO,217) BCG immunizationcoverageamong1-year-olds(%) 1 97 9 94 94 88 89 9 89 8 94 Polioimmunizationcoverageamong1-year-olds(%) 1 92 89 9 85 83 88 8 84 84 83 7 7 6 5 6 5 4 4 3 3 2 2 1 21 211 212 213 214 215 216 217 MCVimmunizationcoverageamong1-year-olds(%) 1 9 8 75 7 74 6 5 4 3 2 1 85 82 83 76 75 21 211 212 213 214 215 216 217 Penta1-Penta3dropoutrate Penta3 Penta1 Dropoutrate 8 Penta3immunizationcoverageamong1-year-olds(%) 1 1 9 83 8 7 6 5 4 3 21 211 212 213 214 215 216 217 82 84 89 92 88 88 85 2 1 21 211 212 213 214 215 216 217 DRAFT Fulyimmunizedchildrenaged12-23months 21-215 68.4 217 88 94-6 216 85 9-5 Childnutrition(Datasource:WHO,215) 215 92 98-6 Lowbirth-weightprevalence(%) 2-215 13 214 88 92-4 Stuntingprevalence(%) 2-215 23.1 213 89 94-5 Overweightprevalence(%) 2-215 4.1 212 84 89-5 Wastingprevalence(%) 2-215 7.1 211 82 88-6 Exclusivebreastfeeding<6months(%) 2-215 48.5 21 83 87-4 Prevalenceofanaemiainpregnantwomen(hb<11 g/dl) 2-215 25.6

Communicablediseases 3, 2, 1, 17, NumberofpeoplelivingwithHIV 17, 18, 18, HIVepidemic(Datasource:WHO 218) 19, 19, 2, 2, 21 211 212 213 214 215 216 217 PrevalenceofHIVamongadultsaged15to 49(%) 2 15 1 5 13 21 12.9 12.8 12.8 12.6 12.5 12.3 12.1 211 212 213 214 215 216 217 4, NumberofdeathsduetoHIV NumberofnewHIVinfections(per1 uninfectedpopulation) 1 2, 3,4 3, 2,6 2,5 2,5 2,7 2,7 2,7 8 21 211 212 213 214 215 216 217 6 15, 1, 5, NumberofnewHIVinfections 9,8 9,3 9,3 9,2 8,5 8,4 7,7 7,4 21 211 212 213 214 215 216 217 4 2 5.34 21 4.97 211 4.89 212 4.75 213 4.29 214 4.12 215 3.68 216 3.49 217 HIVresponses(Datasource:WHO 218) HIVtestingandcounseling 212 214 Numberoftestingandcounselingfacilities 338 Numberoftestingandcounselingfacilitiesper1adultpopulation 22 Numberofpeopleaged15yearsandoverwhoreceivedHIVtestingandcounseling 2,374 Estimatednumberofpeopleaged15yearsandoverwhoreceivedHIVtestingandcounselingper1adult population 177 132 NumberofHIVpeoplereceivingantiretroviraltherapy(ART)by classofages NumberofpeopleunderART 2, 15, 1, 5, 94,3 76,9 9, -14yearsold 15yearsoldandover 1,2 15, 11,2 1,2 134, 117, 121, 1,6 1, 9,6 158, 141, 9,2 21 211 212 213 214 215 216 217 ofhivpeoplereceivingartbyclassofages 1 8 6 4 2 71 51 5 8 61 59 86 78 81 77 76 66 7 7 69 64 7-14yearsold 78 85 84 77 75 77 76 15yearsoldandover Alages 21 211 212 213 214 215 216 217

Numberofpeople NumberofHIVpeople aged15andoverreceiving antiretroviraltherapybysex 1, 8, 6, 4, 62, 5,5 69,8 35,7 4,5 76, 86, 76,4 9,5 44,8 48,5 17, 51, 51,8 ofhivpeople aged15andoverreceiving antiretroviraltherapybysex 1 8 6 4 54 43 65 51 71 55 61 74 73 8 82 95 65 69 71 7 2, 26,4 32,3 2 21 211 212 213 214 215 216 217 21 211 212 213 214 215 216 217 HIVIncidence(%) 15-49years 15-64years HIVprevalence(%) -14years 15-49years 15-64years Urbanareas Ruralareas Viralloadsuppression(%) 15-49years 15-64years PeoplelivingwithHIV(PLHIV)aged15to64wereawareoftheirHIVstatus(%) PLHIVaged15to64whoknewtheirHIVstatusandwereonART(%) PLHIVaged15to64curentlyuseofARTandwereviralysuppressed(%) Viralloadsuppression(Datasource:MinistryofHealth217) Prevalenceofvoluntarymedicalmalecircumcision(Nodata) Bothsexes.67.59 1.1 14.8 15.7 81.7 89.5 97.1 92.2 DRAFT.15.4.13.36 1 1 8 11.5 9.3 12.6 69.6 77.4 79.6 86 94.9 96.4 89.5 91.3 Medicalycircumcised Non-medicalycircumcised Uncircumcised Unknown Prevalenceofsexwithnon-maritalpartnerandcondom useatlastsex(nodata) Condom atlastsexwithnon-maritalpartneramongthosewhoreportedhavingsexwithanon-marital,non-cohabiting partnerinthepast12months(%) Sexwithnon-maritalpartnerin12monthsamongthosewhoreportedhavingsexinthepast12months(%) Progresstowards9-9-9targets(Datasource:UNAIDS218) 215 216 217 ofpeoplelivingwithhivwhoknowtheirstatus 91 93 9 ofpeoplewhoknowtheirstatuswhoareonart 83 84 94 ofpeopleonartwhoachieveviralsuppression 87

TBincidence(Datasource:WHO 218) 21 211 212 213 214 215 216 Numberofincidenttuberculosiscases 14, 14, 13, 12, 11, 12, 11, Incidenceoftuberculosis(per1 populationperyear) 649 61 552 518 48 495 446 Numberofincidenttuberculosiscases (HIV-positivecases) 7,7 6,9 5,9 5,4 4,8 4,8 4,2 Incidenceoftuberculosis(per1 population)(hiv-positivecases) 357 311 259 232 24 2 171 TBtreatmentcoverage(Datasource:WHO 218) 15, Tuberculosis-newandrelapsecases 1 Tuberculosistreatmentcoverage(%) Numberofcases 1, 5, 1,86 11,281 1,3 9,597 9,114 9,614 8,857 5 8 8 8 8 8 8 8 21 211 212 213 214 215 216 21 211 212 213 214 215 216 TBnewcasenotifications(Datasource:WHO 218) 21 211 212 213 214 215 216 Newcases:extrapulmonary 2,33 2,39 2,63 1,846 1,561 1,47 1,448 Newcases:Pulmonary,smear-negative/unknown/notdoneandothernew cases 3,39 3,34 2,473 Newcases:Pulmonary,smear-positive 4,464 4,53 4,333 Neworunknowntreatmenthistorycases:Pulmonary,bacteriologicaly confirmed 4,331 4,42 4,877 4,784 Neworunknowntreatmenthistorycases:Pulmonary,clinicalydiagnosed 2,241 2, 1,514 1,172 Treatmenthistoryunknown TBmortality(Datasource:WHO 218) Numberofdeathsper1population 1 8 6 4 2 DeathsduetotuberculosisamongHIV-negativepeople(per1 population) 32 33 32 31 3 1,5 1, 5 21 211 212 213 214 215 Numberofdeaths 216 Numberofdeathsduetotuberculosis,excludingHIV 7 73 73 79 72 73 75 21 211 212 213 214 215 216 33 3

TBpreviouslytreatedcasenotifications(Datasource:WHO 218) 21 211 212 213 214 215 216 Previouslytreated cases,excludingrelapse 1,344 1,132 1,142 1,13 935 33 297 Relapsecases:extrapulmonary 197 155 Relapsecases:Pulmonary,bacteriologicaly confirmed 1,179 1,133 1,166 1,33 Relapsecases:Pulmonary,clinicaly diagnosed 39 265 TBDrugresistance(Datasource:WHO 218) 21 211 212 213 214 215 216 ConfirmedcasesofRR-/MDR-TB(1) 214 192 21 283 35 32 36 CasesstartedonMDR-TBtreatment NewcasestestedforRR-/MDR-TB(%) Previouslytreatedcasestestedfor RR-/MDR-TB(%) EstimatedMDR/RR-TBcasesamongnotified pulmonarytbcases (1)MDR:Multi-drugresistant;RR:Rifampicin-resistant 2 15 1 5 TBpatientswithknownHIVstatus(%) TestedTBpatientsHIV-positive(%) 76 55 44 214 HIV-positiveTBpatientsonantiretroviraltherapy(%) 84 89 54 72 242 5 47 45 21 211 212 213 214 215 216 288 92 9 8 84 17 Co-epidemicsofTBandHIV(Datasource:WHO 218) DRAFT 327 98 92 38 98 94 44 4 38 362 2.6 1 48 12 1 8 6 Tuberculosistreatmentcoverage(%) Treatmentsuccessrate:newTBcases(%) Treatmentsuccessrate:previouslytreatedTBcases(%) 85 86 85 86 87 8 8 8 8 8 8 78 78 78 TBtreatmentsuccess(Datasource:WHO 218) 83 8 8 71 6 21 211 212 213 214 215 216 1 TreatmentsuccessrateforpatientstreatedforMDR-TB(%) Treatmentsuccessrate:HIV-positiveTBcases(%) 9 81 81 8 8 78 79 7 72 68 7 64 6 58 59 5 21 211 212 213 214 215 216

Malariacasesanddeaths(Datasource:WHO 217) 212 213 214 215 216 27-213 Estimatedmalariacases 7, 9, 28,77 21,99 45,5 Numberofmalariacasesper1, populationatrisk 493 619 1,933 1,444 2,923 Estimatedmalariadeaths 12 Malariamortalityrateper1,population 8 Childrenaged<5yearssleepingunder insecticide-treatednets(%) 6 Proportionofchildrenunder5yearsofagewith feverbeing treatedwithantimalarialdrugs 2 Insecticideclassresistance(Datasource:WHO 217) 21 215 Numberofinsecticideclassestowhichresistancewasreported Nottested/reported Nottested/reported Neglectedtropicaldiseasescasesanddeaths(Nodata) 212 213 214 215 216 217 Leprosy-numberofreportedcases Numberofnewreportedcasesofhumanafrican trypanosomiasis(t.b.rhodesiense) Numberofpeopleoperatedfortrachomatoustrichiasis Numberofpeoplewhoreceivedtreatmentwithantibioticsfor trachoma Estimatednumberofindividualsinthecountryrequiring preventivechemotherapyforonchocerciasis Reportednumberofindividualstreatedforonchocerciasis Numberofcasesofcutaneousleishmaniasisreported

Neglectedtropicaldiseasesstatusofendemicity(Datasource:WHO 218) 213 216 218 Statusofendemicityofonchocerciasis Nodata Statusofendemicityofvisceralleishmaniasis Noautochthonouscases reported Statusofendemicityofcutaneousleishmaniasis Endemic Statusofbejelendemicity Previouslyendemic(curent statusunknown) Statusofeliminationoftrachomaasapublichealthproblem Statusofyawsendemicity Noprevioushistoryofyaws Choleracasesanddeaths(Datasource:WHO 218) Statusuncertain 213 214 Numberofreportedcasesofcholera 3. 485. Numberofreporteddeathsfrom cholera. 13. DRAFT Choleracasefatalityrate(%). 2.7 Meningitiscasesanddeaths(Nodata) 21 211 212 213 214 Numberofsuspectedmeningitisdeathsreported Syphilis(Datasource:WHO 218) 21 214 217 Womenaccessingantenatalcare(ANC)serviceswhowere testedforsyphilis(%) 93.8 78.2 97.9 Antenatalcareatendeeswhowerepositiveforsyphilis(%) 1.9 2.1

Adults 18yearswithraisedbloodpressure(%) 1 9 8 7 6 5 4 3 29.5 28.5 29.3 29.1 28.9 28.7 2 1 21 211 212 213 214 215 Noncommunicablediseases Adults 18yearswithraisedbloodpressure,bysex(%) 29.5 29.4 29.3 29.2 29.1 29. 28.9 28.8 28.7 28.6 28.5 28.4 28.3 28.2 28.1 28. 29.3 29.4 29.1 29.2 28.9 29. 28.7 28.8 28.4 28.6 28.2 28.4 21 211 212 213 214 215 Adults 18yearswithraisedfastingbloodglucose(%) 1 Adults 18yearswithraisedfastingbloodglucose,bysex (%) 9 8 7 7.5 7.4 7.3 7.4 7.5 6 5 4 3 2 1 6.9 7.4 7. 7.2 7.3 21 211 212 213 214 7.2 7.1 7. 6.9 6.8 6.7 6.6 6.5 7.3 7.3 7.2 7.2 7.1 7. 6.8 6.7 21 211 212 213 214 Adults 18yearswhowereoverweight(%) 1 Adults 18yearswhowereoverweight,bysex(%) 9 8 7 5 45 46.9 47.8 48.6 49.4 5.3 51.1 51.9 6 5 4 35.8 3 36.6 37.4 38.2 39. 39.8 4.6 4 35 3 2 1 21 211 212 213 214 215 216 25 2 26.4 27.2 25.5 24.7 24. 22.5 23.2 21 211 212 213 214 215 216

Adults 18yearswhowereobese(%) 1 9 8 7 6 5 4 3 Adults 18yearswhowereobese,bysex(%) 26 24 22 2 18 16 14 12 1 24.7 24.1 23.4 22.7 22. 21.4 25.4 Percapitaalcoholconsumptionamongpeople 15years (%) 2 1 14. 1 9 8 7 6 5 4 3 2 1 21 211 212 213 214 215 216 7.4 14.6 7.7 15.1 6.3 15.6 16.1 7.8 16.7 7.8 17.2 7.8 21 211 212 213 214 215 8 6 4 5.2 5.5 5.9 6.3 6.7 7.1 7.5 21 211 212 213 214 215 216 individuals 15yearswho usedtobacco ofadults 18yearswith insuficientphysicalactivity 215 21 ageofadults 25yearswith 28 raisedcholesterol DRAFT 7.7 37.1 34.5 27.6 26.4 31.1 Both sexes 17.2 31.8 33.1

Serviceavailabilityandreadiness(Nodata) Readinesstoprovidegeneralservices Healthsystemsandservices Nodata Basicamenities Basicequipment Diagnostics Essentialmedicines Standardprecautionsfor infectionpreventionand control GeneralService ReadinessIndex Themeanavailabityofitemsforoferingthespecific services(%) Adolescenthealthservices Advanceddiagnosticservices Antenatalcare ART Basicobstetriccare Basicsurgery Bloodtransfusion Cardiovasculardiseases CEmOC Cervicalcancerscreening Childimmunization Chronicobstructiverespiratorydisease Comprehensivesurgery Diabetes Familyplanning High-leveldiagnosticservices HIVcareandsupport HIVcounselingandtesting Life-savingmedicine(children) Life-savingmedicines(mothers) Malaria PMTCT Preventiveandcurativeservicesforunder-fives STIs TB offacilitiesthatreportedoferingservices,by servicestype Adolescenthealthservices Antenatalcare ART Basicobstetriccare Basicsurgery Bloodtransfusion Cardiovasculardiseases CEmOC Cervicalcancerscreening Childimmunization Chronicobstructiverespiratorydisease Comprehensivesurgery Diabetes Familyplanning HIVcareandsupport HIVcounselingandtesting Malaria PMTCT Preventive&curativeservices STIs TB Serviceavailabilityindex Healthfinancing(Datasource:WHO 218) DomesticGeneralGovernmentHealthExpenditure(cGGHE-D)per CapitainPPPInt$ US$ 6 5 4 423.8 3 2 457.5 453.2 491.4 529.9 593.6 CurentDomesticGeneralGovernmentHealthExpenditure (cgghe-d)as% GeneralGovernmentExpenditure(GGE) 16 15.4 14 12 1 8 6 4 13.7 14.2 14. 12.9 12.9 1 2 21 211 212 213 214 215 21 211 212 213 214 215

Healthfinancing(Datasource:WHO 218) BreakdownofTotalCurenteHealthExpenditurebysource(%) 1 9 8 7 54. 54. 54. 59.4 64. 63. 6 5 4 Out-of-pocket(OOPS)as% oftotalcurenthealthexpenditure (CHE)(Datasource:WHO 218) US$ 5 45 4 35 3 25 2 3 2 1 33.3 35.4 38. 33.7 3. 27.8 12.7 1.6 8. 6.9 6. 9.3 21 211 212 213 214 215 15 1 5 9.5 1.4 11. 9.9 9. 21 211 212 213 214 215 8.3 CurenteDomesticGeneralGovernmentHealthExpenditure(GGHE-D)as% TotalCurentHealthExpenditure(CHE) DomesticPrivateHealthExpenditure(PVT-D)as% CurentHealthExpenditure(CHE) ExternalHealthExpenditure(EXT)as% ofcurenthealthexpenditure(che) CurentHealthExpenditure(CHE)as% GrossDomesticProduct(GDP) DomesticGeneralGovernmentHealthExpenditure(GGHE-D)as% GrossDomesticProduct(GDP) ExternalHealthExpenditureChanneledthroughGovernment(EXT-G)as% ofexternalhealth Expenditure(EXT) DomesticHealthExpenditure(DOM)as% ofcurenthealthexpenditure(che) CurentHealthExpenditure(CHE)perCapitainPPP DomesticPrivateHealthExpenditure(PVT-D)perCapitainPPPInt$ ExternalHealthExpenditure(EXT)perCapitainPPPInt$ CurentHealthExpenditure(CHE)perCapitainUS$ DomesticGeneralGovernmentHealthExpenditure(GGHE-D)perCapitainUS$ DomesticPrivateHealthExpenditure(PVT-D)perCapitainUS$ 21 211 212 213 214 215 ExternalHealthExpenditure(EXT)perCapitainUS$ 62.4 57.8 42.3 32.8 26.5 39.2 Healthworkforce(Datasource:WHO 218) Physiciansdensity(per1population) Nursingandmidwiferypersonneldensity(per1population) 9.5 5.1 47. 87.3 784.8 261.3 99.7 491.5 265.4 163.6 9.7 5.2 19.6 89.4 847.3 299.8 9. 544.2 293.8 192.5 DRAFT Otherhealthworkersdensity(per1population).16 9.2 5. 19.6 92. 839.2 318.9 67.1 528.3 285.3 2.8 8.6 5.1 19.6 93.1 827.6 279. 57.3 474. 281.4 159.8 8.2 5.2 19.6 94. 827.9 248.4 49.7 442.4 283.2 132.7 8.9 5.6 19.6 9.7 942.5 261.6 87.3 423.1 266.5 117.4 27.37 2.76 Medicalproducts,infrastructuresandequipment(Datasource:WHO 218) Availabilityoftechnicalspecificationsofmedicaldevicestosupportprocurementordonations No Availabilityofnationallistofapprovedmedicaldevicesforprocurementorreimbursement No Essentialmedicines(Nodata)

Medicalproducts,infrastructuresandequipment(Datasource:WHO 218) Equipment Totaldensitypermilionfemalesagedfrom 5to69 yearsold:mammographyunits Totaldensitypermilionpopulation:Computed tomographyunits 21 213 214 42.24 42.3 4.82 4.78 Bedsdensity Bedsformentalhealthingeneralhospitals(per 1,) 211 214 8.27 12.1 Bedsinmentalhospitals(per1,) 29 Totaldensitypermilionpopulation:Gammacamera ornuclearmedicine.88.87 Hospitalbeds(per1population) 54 Totaldensitypermilionpopulation:Linear Accelerator.. Infrastructures:Totaldensityper1population 21 213 Totaldensitypermilionpopulation:Magnetic ResonanceImaging.88.87 Hospitals District/ruralhospitals 1.31 1.91 1.3 Totaldensitypermilionpopulation:Positron Emissiontomography.. Provincialhospitals.18.17 Totaldensitypermilionpopulation:Radiotherapy units.44.43 Specializedhospitals Healthcentres.44 2.32.43 2.3 Totaldensitypermilionpopulation:TelecobaltUnit.44.43 Healthposts 12.88 12.76 Healthinformation,evidenceandknowledge Censuscariedout(Datasource:UNSD216) Censuscariedoutinthe21roundofcensuses(25-214) Censuscariedoutinthe22roundofcensuses(215-224) Yes Itisexpectedthatacensuswilbeheldonthedateindicated Civilregistration(Datasource:WHO,218) CauseofDeathReportingatHealthFacilities(%):withMCCoD/ICDCompliance 217 4 Civilregistrationcoverageofbirths(%) 87.1 ehealth(datasource:itu,218) Celularormobilesubscribersper1inhabitants ageofindividualsusingtheinternet 21 211 212 213 214 215 216 217 89.7 99. 94.8 117.8 112.7 15.1 17.3 14.5 11.6 12. 12.9 13.9 14.8 25.7 31.

Waterandsanitation(Datasource:WHO,215) Populationusingimproveddrinkingwatersource(%) 1 9 8 7 6 5 4 3 2 1 1 9 8 7 6 5 4 3 2 1 69.6 24. 78.5 199 2 215 Populationusingimprovedsanitation(%) 27.4 199 2 215 Socialdeterminantsofhealth 34.4 Accesstoelectricity(Datasource:WorldBank,215) Populationwithaccesstoelectricity(%) 1 9 8 7 6 5 4 45.4 46.4 3 2 1 47.5 47.4 49.6 5.7 91 51.8 21 211 212 213 214 215 216 Populationusingimproveddrinkingwatersource,by residencearea(%) Populationwithaccesstoelectricity,byresidencearea(%) 1 9 8 7 6 5 4 3 2 1 1 9 8 7 6 5 4 3 2 1 1 9 8 7 74.7 6 5 4 3 2 24.5 1 Rural Urban 58.4 199 2 215 98.7 Rural Urban Rural Urban Rural Urban 9.8 75.1 25.1 75.5 25.8 68.9 72.2 2.5 98.5 76.3 27.2 84.6 199 2 215 61 12.6 58.4 16.8 76.7 27.9 98.2 Populationusingimprovedsanitation,byresidencearea (%) Rural Urban DRAFT 54.5 Rural Urban Rural Urban Rural Urban Rural Urban 77.1 28.7 21 211 212 213 214 215 216